Eva Péterfai
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Chronic Kidney Disease and Diabetes, Metabolism, Diabetes, and Cancer, Diet and metabolism studies
Most-Cited Works
- → Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial(2017)289 cited
- → Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study(2018)229 cited
- → Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial(2009)112 cited
- → Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557(2009)67 cited
- → Beneficial effect of the insulin sensitizer (HSP inducer) BGP-15 on olanzapine-induced metabolic disorders(2010)33 cited
- → Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial(2014)27 cited
- Practical aspects of measuring microalbuminuria in diabetic patients.(2001)
- [The cognitive effect of alprazolam in healthy volunteers].(2006)
- → The regulation of energy metabolism — Bone metabolic activity connection is gender-specific(2009)2 cited
- → The effect of insulin sensitizer BGP-15 on olanzapine induced metabolic disorders(2012)